发明名称 |
MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES |
摘要 |
<P>PROBLEM TO BE SOLVED: To provide an antisense approach to prevent and/or reverse an autoimmune diabetes condition in NOD mice. <P>SOLUTION: AS-oligonucleotides are delivered in microsphere form in order to induce dendritic cell tolerance, particularly in the non-obese-diabetic (NOD) mouse model. The microspheres incorporate antisense (AS) oligonucleotides. A process includes using an antisense approach to reverse an autoimmune diabetes condition in NOD mice in vivo. The oligonucleotides are targeted to bind to primary transcripts CD40, CD80, CD86 and their combinations. <P>COPYRIGHT: (C)2012,JPO&INPIT |
申请公布号 |
JP2012180376(A) |
申请公布日期 |
2012.09.20 |
申请号 |
JP20120142190 |
申请日期 |
2012.06.25 |
申请人 |
BAXTER INTERNATL INC;BAXTER HEALTHCARE SA;UNIV OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION |
发明人 |
BROWN LARRY R;GIANNOUKAKIS NICK;GILLIS KIMBERLY A |
分类号 |
A61K48/00;A61K9/127;A61K31/7088;A61K38/28;A61P3/10;A61P5/48;A61P43/00;C12N15/113 |
主分类号 |
A61K48/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|